eginning August 1, Switzerland will no longer require medical cannabis patients to request permission from the Federal Office of Public Health (FOPH), allowing them to get prescriptions directly from their doctors, Forbes reports. The new rules effectively legalize medical cannabis nationally and allow the export of medical cannabis for commercial purposes, although the products are capped at 1% THC.
The reforms follow Switzerland’s Federal Council’s lifting of the ban on cannabis for medical purposes by amending the Swiss Narcotics Act, which Parliament approved in March 2021, the report says. Exporters still need permission from Swissmedic.
